explore -WSS

explore

author：knowledge 2025-10-02 18:06:01 - browse：5

Amid the stunning rebuke Amgen suffered at the hands of the U.S. Food and Drug Administration this week lurk numerous questions. And one of them may be whether the company was fully forthcoming about a pricey lung cancer drug that is supposed to generate key revenue growth.

At issue is a trial that Amgen is relying upon to win final approval for Lumakras, which the FDA approved on a conditional basis in 2021. This process, known as accelerated approval, required the company to run a confirmatory study. But ahead of an advisory panel meeting on Thursday, the agency released documents showing its staff found “potential systemic bias” in the trial.

The disclosure throws into question the future of this drug, which has offered hope to patients for whom an effective treatment previously seemed out of reach. Some Wall Street analysts are now betting the FDA will ask Amgen to run yet another trial or maybe withdraw the drug altogether. Either way, the prognosticators are reworking their calculus for Amgen stock.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Lilly’s weekly insulin works as well as daily products, new studies show

WSS

Judge in Trump's classified documents case questions use of out

Kansas bar where gunfire wounded 9 last month closes permanently

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

Doctors are clamoring for more clarity on Paxlovid prescribing

Sage considers ways to reduce costs following FDA rejection

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

focus

explore

entertainment

United colonoscopy coverage change 'may cost lives,' doctors say

Sweden knocks USA out of World Cup in penalty kicks

Trump demands the U.S. pay no more for drugs than other countries … again

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

United colonoscopy coverage change 'may cost lives,' doctors say

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Alkermes shareholders re

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

Tori Bowie and the unacceptable rates of Black maternal death

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

hotspot

CVS is willing to dump 10% of its Medicare Advantage members

How CRISPR works, explained in two minutes

Boston hospital trains restaurant workers on naloxone for overdoses

Doctors push to include dialysis machines in emergency stockpile

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

With heat waves through August, officials warn of health risks

Wikipedia

focus

focus

Wikipedia